Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents
Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis, and cell cycle arrest in cancer cells. Recently, their use has been clinically validated in cancer patients resultin...
Saved in:
Published in | Current medicinal chemistry |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United Arab Emirates
01.01.2020
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!